Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03371706 · ClinicalTrials.gov registry record · NA
Communication Bridge 2
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT03371706 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 190 participants.
The verdict
NCT03371706, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech language therapy on communication abilities in individuals with PPA. Participants with a diagnosis of PPA and their actively-engaged care partners will be involved in the study for 12 months. Each participant will receive a laptop equipped with the necessary applications and features for the study. Participants will receive 5 evaluations and 15 speech therapy sessions with a licensed speech therapist, as well as access to Communication Bridge, a personalized web application to practice home exercises that reinforce treatment strategies. There are no costs to participate in this study.
Interventions
- BEHAVIORAL Communication Bridge™
- BEHAVIORAL Evidence-Based Impairment Focused
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2018-04-03 |
| Est. Completion | 2023-03-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03371706
The ClinicalTrials.gov registry entry for NCT03371706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Communication Bridge™ is the first listed.
NCT03371706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03371706 about?
NCT03371706 is a clinical study titled "Communication Bridge 2". This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech language therapy on communication abilities in individua...
What is the current status of trial NCT03371706?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2018-04-03. Estimated completion is 2023-03-23.
What interventions are being tested in trial NCT03371706?
The interventions under investigation include: Communication Bridge™ (BEHAVIORAL), Evidence-Based Impairment Focused (BEHAVIORAL).
Who is sponsoring clinical trial NCT03371706?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.